Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients.

Fracchiolla NS, Artuso S, Cortelezzi A, Pelizzari AM, Tozzi P, Bonfichi M, Bocchio F, Gargantini L, De Rosa E, Vighi GD, Prestini L, Sammassimo S, Frungillo N, Pasquini MC, Ragazzi A, Boghi D, Pastore A, Lanzi E, Gritti G, Quaresmini G, Voltolini S, Gaiardoni R, Corti C, Vilardo MC, La Targia ML, Berini G, Magagnoli M, Bacci C, Consonni D, Rivolta AL, Muti G.

Hematol Oncol. 2017 Aug 3. doi: 10.1002/hon.2451. [Epub ahead of print]

PMID:
28771763
2.

Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.

Gnani D, Romito I, Artuso S, Chierici M, De Stefanis C, Panera N, Crudele A, Ceccarelli S, Carcarino E, D'Oria V, Porru M, Giorda E, Ferrari K, Miele L, Villa E, Balsano C, Pasini D, Furlanello C, Locatelli F, Nobili V, Rota R, Leonetti C, Alisi A.

Cell Death Differ. 2017 May;24(5):889-902. doi: 10.1038/cdd.2017.34. Epub 2017 Mar 24.

3.

Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma Growth.

Salzano G, Zappavigna S, Luce A, D'Onofrio N, Balestrieri ML, Grimaldi A, Lusa S, Ingrosso D, Artuso S, Porru M, Leonetti C, Caraglia M, De Rosa G.

J Biomed Nanotechnol. 2016 Apr;12(4):811-30.

PMID:
27301207
4.

Intragenic G-quadruplex structure formed in the human CD133 and its biological and translational relevance.

Zizza P, Cingolani C, Artuso S, Salvati E, Rizzo A, D'Angelo C, Porru M, Pagano B, Amato J, Randazzo A, Novellino E, Stoppacciaro A, Gilson E, Stassi G, Leonetti C, Biroccio A.

Nucleic Acids Res. 2016 Feb 29;44(4):1579-90. doi: 10.1093/nar/gkv1122. Epub 2015 Oct 27.

5.

Targeting G-Quadruplex DNA Structures by EMICORON Has a Strong Antitumor Efficacy against Advanced Models of Human Colon Cancer.

Porru M, Artuso S, Salvati E, Bianco A, Franceschin M, Diodoro MG, Passeri D, Orlandi A, Savorani F, D'Incalci M, Biroccio A, Leonetti C.

Mol Cancer Ther. 2015 Nov;14(11):2541-51. doi: 10.1158/1535-7163.MCT-15-0253. Epub 2015 Aug 24.

6.

Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report.

Annaloro C, Costa A, Fracchiolla NS, Mometto G, Artuso S, Saporiti G, Tagliaferri E, Grifoni F, Onida F, Cortelezzi A.

Clin Case Rep. 2015 Jul;3(7):650-5. doi: 10.1002/ccr3.308. Epub 2015 Jun 11.

7.

Drug-releasing mesenchymal cells strongly suppress B16 lung metastasis in a syngeneic murine model.

Pessina A, Leonetti C, Artuso S, Benetti A, Dessy E, Pascucci L, Passeri D, Orlandi A, Berenzi A, Bonomi A, Coccè V, Ceserani V, Ferri A, Dossena M, Mazzuca P, Ciusani E, Ceccarelli P, Caruso A, Portolani N, Sisto F, Parati E, Alessandri G.

J Exp Clin Cancer Res. 2015 Aug 13;34:82. doi: 10.1186/s13046-015-0200-3.

8.

TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children.

Rossi E, Basso D, Zambon CF, Navaglia F, Greco E, Pelloso M, Artuso S, Padoan A, Pescarin M, Aita A, Bozzato D, Moz S, Cananzi M, Guariso G, Plebani M.

PLoS One. 2015 Apr 27;10(4):e0123244. doi: 10.1371/journal.pone.0123244. eCollection 2015.

9.

Erratum: identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities.

Rizzo A, Iachettini S, Zizza P, Cingolani C, Porru M, Artuso S, Stevens M, Hummersone M, Biroccio A, Salvati E, Leonetti C.

J Exp Clin Cancer Res. 2015 Feb 5;34:9. doi: 10.1186/s13046-014-0101-x. No abstract available.

10.

A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.

Graziani G, Artuso S, De Luca A, Muzi A, Rotili D, Scimeca M, Atzori MG, Ceci C, Mai A, Leonetti C, Levati L, Bonanno E, Tentori L, Caccuri AM.

Biochem Pharmacol. 2015 May 1;95(1):16-27. doi: 10.1016/j.bcp.2015.03.004. Epub 2015 Mar 17.

PMID:
25795251
11.

Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid.

Porru M, Zappavigna S, Salzano G, Luce A, Stoppacciaro A, Balestrieri ML, Artuso S, Lusa S, De Rosa G, Leonetti C, Caraglia M.

Oncotarget. 2014 Nov 15;5(21):10446-59.

12.

Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities.

Rizzo A, Iachettini S, Zizza P, Cingolani C, Porru M, Artuso S, Stevens M, Hummersone M, Biroccio A, Salvati E, Leonetti C.

J Exp Clin Cancer Res. 2014 Oct 6;33:81. doi: 10.1186/s13046-014-0081-x. Erratum in: J Exp Clin Cancer Res. 2015;34:9.

13.

Comorbidities and polypharmacy impact on complete cytogenetic response in chronic myeloid leukaemia elderly patients.

Iurlo A, Ubertis A, Artuso S, Bucelli C, Radice T, Zappa M, Cattaneo D, Mari D, Cortelezzi A.

Eur J Intern Med. 2014 Jan;25(1):63-6. doi: 10.1016/j.ejim.2013.11.002. Epub 2013 Dec 2.

PMID:
24309387
14.

Biosensors in clinical practice: focus on oncohematology.

Fracchiolla NS, Artuso S, Cortelezzi A.

Sensors (Basel). 2013 May 14;13(5):6423-47. doi: 10.3390/s130506423. Review.

15.

Gastric ulcer penetration into the liver mimicking malignancy on endoscopic ultrasound.

Kypraios D, Fusaroli P, Artuso S, Poli F, Caletti G.

Endosc Ultrasound. 2013 Apr;2(2):107-8. doi: 10.4103/2303-9027.117700. No abstract available.

16.

Factors influencing health care utilisation among Aboriginal cardiac patients in central Australia: a qualitative study.

Artuso S, Cargo M, Brown A, Daniel M.

BMC Health Serv Res. 2013 Mar 6;13:83. doi: 10.1186/1472-6963-13-83.

17.

A nitric oxide-dependent cross-talk between class I and III histone deacetylases accelerates skin repair.

Spallotta F, Cencioni C, Straino S, Nanni S, Rosati J, Artuso S, Manni I, Colussi C, Piaggio G, Martelli F, Valente S, Mai A, Capogrossi MC, Farsetti A, Gaetano C.

J Biol Chem. 2013 Apr 19;288(16):11004-12. doi: 10.1074/jbc.M112.441816. Epub 2013 Mar 5.

18.

Molecular imaging of nuclear factor-Y transcriptional activity maps proliferation sites in live animals.

Goeman F, Manni I, Artuso S, Ramachandran B, Toietta G, Bossi G, Rando G, Cencioni C, Germoni S, Straino S, Capogrossi MC, Bacchetti S, Maggi A, Sacchi A, Ciana P, Piaggio G.

Mol Biol Cell. 2012 Apr;23(8):1467-74. doi: 10.1091/mbc.E12-01-0039. Epub 2012 Feb 29.

19.

Transcription factor NF-Y induces apoptosis in cells expressing wild-type p53 through E2F1 upregulation and p53 activation.

Gurtner A, Fuschi P, Martelli F, Manni I, Artuso S, Simonte G, Ambrosino V, Antonini A, Folgiero V, Falcioni R, Sacchi A, Piaggio G.

Cancer Res. 2010 Dec 1;70(23):9711-20. doi: 10.1158/0008-5472.CAN-10-0721. Epub 2010 Oct 15.

20.

The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms.

Manni I, Artuso S, Careccia S, Rizzo MG, Baserga R, Piaggio G, Sacchi A.

FASEB J. 2009 Nov;23(11):3957-66. doi: 10.1096/fj.09-131847. Epub 2009 Jul 16.

PMID:
19608627

Supplemental Content

Loading ...
Support Center